Insulin resistance and atherosclerosis in branch retinal vein occlusion

被引:8
作者
Ogawa, O
Onuma, T
Uchino, H
Takayanagi, Y
Tanaka, Y
Yamasaki, Y
Atsumi, Y
Matsuoka, K
Kawamori, R
机构
[1] Juntendo Univ, Sch Med, Dept Med Metab & Endocrinol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Takayanagi Eye Clin, Kushiro, Japan
[3] Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Osaka, Japan
[4] Saiseikai Cent Hosp, Dept Med, Tokyo, Japan
关键词
atherosclerosis; branch retinal vein occlusion; insulin resistance;
D O I
10.1016/S0021-5155(03)00059-5
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To investigate insulin resistance and atherosclerotic change in patients with branch retinal vein occlusion (BRVO). Subjects: Sixty-three patients with BRVO, 859 age- and sex-matched control subjects without BRVO who received the 75-g oral glucose tolerance test (OGTT), and 53 control subjects, in whom carotid artery intima-media thickness (IMT) was measured by high-resolution ultrasonography, were included in this study. Results: The area under the curve of immunoreactive insulin in plasma during the OGTT was higher in patients with BRVO than in control subjects without BRVO, both when comparing individuals with normal glucose tolerance (P = .013) and when comparing individuals with impaired Glucose tolerance (P < .005). Patients with BRVO showed greater IMT than control subjects, but the differences were significant only in the group aged 50-59 years and in the group older than 70 years. Conclusions: insulin resistance may play some role in the onset or progression of BRVO. (C) 2003 Japanese Ophthalmological Society.
引用
收藏
页码:351 / 355
页数:5
相关论文
共 27 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]   Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects [J].
Calles-Escandon, J ;
Mirza, SA ;
Sobel, BE ;
Schneider, DJ .
DIABETES, 1998, 47 (02) :290-293
[4]   Antiphospholipid antibodies and retinal thrombosis in patients without risk factors:: A prospective case-control study [J].
Cobo-Soriano, R ;
Sánchez-Ramón, S ;
Aparicio, MJ ;
Teijeiro, MA ;
Vidal, P ;
Suárez-Leoz, M ;
Rodriguez-Mahou, M ;
Rodriguez-Huerta, A ;
Fernández-Cruz, E ;
Cortés, C .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1999, 128 (06) :725-732
[5]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[6]   Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Schneider, DJ ;
Sobel, BE ;
Cavaghan, MK ;
Imperial, J ;
Rosenfield, RL ;
Polonsky, KS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) :2108-2116
[7]   Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance -: The Insulin Resistance Atherosclerosis Study (IRAS) [J].
Festa, A ;
D'Agostino, R ;
Mykkänen, L ;
Tracy, RP ;
Zaccaro, DJ ;
Hales, CN ;
Haffner, SM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :562-568
[8]  
FRANGIEH GT, 1982, ARCH OPHTHALMOL-CHIC, V100, P1132
[9]  
Glueck CJ, 1999, ARCH OPHTHALMOL-CHIC, V117, P43
[10]   Insulin sensitivity and atherosclerosis [J].
Howard, G ;
OLeary, DH ;
Zaccaro, D ;
Haffner, S ;
Rewers, M ;
Hamman, R ;
Selby, JV ;
Saad, MF ;
Savage, P ;
Bergman, R .
CIRCULATION, 1996, 93 (10) :1809-1817